Askpot
← Company directory

Debiopharm: SWOT analysis

Debiopharm is an independent biopharmaceutical company based in Switzerland focused on developing innovative solutions to cure cancer and infectious diseases. The company is dedicated to improving patient quality of life through drug development, manufacturing, and digital health investments.

Strengths

  • Debiopharm has a long-standing experience in the biopharmaceutical industry, having been established in 1979, which provides a solid foundation of expertise.

  • The company boasts a dedicated team of 420 professionals, enhancing its capacity for innovation and effective drug development.

  • Debiopharm's unique business model focuses on in-licensing innovative compounds, allowing for a diverse and adaptable portfolio.

  • The commitment to improving patient care through innovative solutions positions Debiopharm as a leader in patient-centric drug development.

  • Debiopharm has established a strong reputation for its comprehensive drug manufacturing capabilities, ensuring quality and efficiency.

  • The company's investment in digital health and smart data start-ups reflects its forward-thinking approach and adaptability to industry trends.

  • Debiopharm's focus on corporate responsibility and societal contribution enhances its brand image and fosters trust among stakeholders.

  • The strong financial position indicated by recent funding activities, such as the investment in MedaSystems, showcases Debiopharm's ability to support growth and innovation.

Weaknesses

Sign in to access Weaknesses

This content is available to registered users.

Sign in

Opportunities

Sign in to access Opportunities

This content is available to registered users.

Sign in

Threats

Sign in to access Threats

This content is available to registered users.

Sign in